Glanbia : Inflation in whey prices set to penalise GPN’s EBITDA margin in 2025, especially in H1
>GPN’s 2025 margin is expected in line with H2 2024 at 15% as whey prices are expected to continue rising until H1 2025 - GPN’s organic growth of -0.8%, in 9M as in Q3, reflected a volume effect of 3.2% which was partly offset by a price effect of -4%. Sales were almost flat in the Americas despite SlimFast having a negative impact (-33%). Excluding this effect, growth would have reached 5%. GPN is growing internationally (+4.7%) thanks to healthy momentum in its ON ...Glanbia is a performance nutrition and ingredients group, engaged in providing performance nutrition, cheese, dairy ingredients, specialty non-dairy ingredients and vitamin and mineral premixes. Co. segments include: Global Performance Nutrition, which is involved in the branded performance nutrition business; Global Ingredients, which manufactures cheddar cheese, provides dairy and non-dairy nutritional ingredients and micro-nutrient premixes; Dairy Ireland, which is engaged in the manufacture and sale of a range of consumer products and farm inputs; and Joint Ventures & Associates, which is engaged in the manufacture and sale of cheese, dairy ingredients and dairy consumer products.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.